Aug 6, 2026 11:02AM
Aug 6, 2026 11:01AM
Apr 22, 2026 06:53AM
Feb 18, 2026 07:29AM
Feb 18, 2026 03:49AM
Nov 6, 2025 11:02AM
Sep 29, 2025 01:08AM Genmab agrees to acquire Merus for $8 billion in all-cash deal
Sep 29, 2025 01:08AM
Aug 7, 2025 11:08AM
May 14, 2025 07:51AM
Feb 13, 2025 07:17AM
Nov 7, 2024 05:56AM
Nov 6, 2024 11:01AM
Aug 8, 2024 11:03AM Genmab Announces Financial Results for the First Half of 2024
Aug 8, 2024 11:01AM
Aug 8, 2024 11:00AM
Aug 8, 2024 11:00AM
May 21, 2024 11:07AM
May 21, 2024 11:06AM
May 2, 2024 11:01AM
Apr 29, 2024 06:55PM Pfizer (PFE), Genmab A/S (GMAB) FDA Grants Full Approval for TIVDAK
Apr 29, 2024 06:40PM
Apr 29, 2024 06:40PM
Apr 3, 2024 05:41AM
Apr 3, 2024 01:34AM
Feb 23, 2024 05:07AM
Jan 9, 2024 06:45AM
Jan 9, 2024 06:45AM TIVDAK® (tisotumab vedotin-tftv) Supplemental Biologics License Application Accepted for Priority Review by U.S. Food and Drug Administration for Patients with Recurrent or Metastatic Cervical Cancer
Jan 9, 2024 06:45AM
Nov 7, 2023 11:01AM
Aug 3, 2023 11:01AM
Jul 27, 2023 06:01PM
May 10, 2023 11:01AM
Nov 9, 2022 11:01AM
Nov 3, 2022 12:45PM Genmab Improves Its 2022 Financial Guidance
Aug 10, 2022 11:01AM
Aug 8, 2022 12:34PM
Aug 8, 2022 12:33PM
May 11, 2022 11:01AM
Nov 10, 2021 11:00AM
Nov 4, 2021 04:24PM
Aug 12, 2021 10:55AM Genmab A/S (GEN:DC) (GMAB) PT Raised to $50 at Truist Securities, Following Earnings
Aug 11, 2021 11:01AM
May 5, 2021 11:01AM
Apr 13, 2021 09:26AM
Nov 19, 2020 07:00AM
Nov 4, 2020 11:04AM
Sep 23, 2020 03:26AM
Aug 12, 2020 11:23AM Genmab Announces Financial Results for the First Half of 2020
May 6, 2020 11:01AM

1,216,190 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All